basal insulin with glp 1 glp-1_analogs [TUSOM Glucagon-like peptide-1 receptor: mechanisms and

These pathways position GLP-1RAs as potential modulators of autoimmunity by attenuating chronic low-grade inflammation and shifting immune balance toward regulation

It works best as part of a comprehensive plan including compression, lymphatic massage, and medical monitoring

Currently, many clinical practice guidelines, including the consensus guideline of the American Diabetes Association and the European Association for the Study of Diabetes, recommend glucagon-like peptide-1 receptor agonist (GLP-1RA) as the first-line injectable agent ahead of basal insulin for most patients with T2DM ( So far, two different products containing fixed-ratio combinations (FRCs) of basal insulin and GLP-1RA were approved by the US Food and Drug Administration and European Medicines Agency: IGlarLixi, which is a combo of insulin glargine and lixisenatide, and IDegLira, which is a combo of insulin degludec and liraglutide ( Based on these backgrounds, this study aimed to evaluate the overall effect of adding basal insulin on persisting GLP-1RA treatment

Original research and review articles published within the last ten years were included in the study, while manuscripts without available full text were excluded

Slow insertion drags the needle through nerve-rich tissue, stimulating more pain receptors along the way